BioMarin Pharmaceutical Inc. (BMRN) has a market capitalization of $10.67B and trades at $55.47. The 52-week range is 50.76-66.28.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 30.5, Earnings Per Share (EPS) of $1.82, annual revenue of $3.22B.
The stock has a beta of 0.29, operates in the Healthcare sector.
